|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 324.48 DKK | -1.07% |
|
+1.55% | -0.18% |
| 12:55am | Nordic stocks in North America, Astra Zeneca fell 1.4% | FW |
| Jul. 20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
Insider Transaction History
Latest insider transactions for Novo Nordisk A/S
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 11/18/25 | Buy | Director | 6,450 | 312.50 | 2.02M | 0.0002% | ||
| 11/18/25 | Sell | 8,160 | 297.95 | 2.43M | 0.0002% | |||
| 11/18/25 | Others | 18,634 | - | - | 0.0005% | |||
| 8/20/25 | Buy | Director | 598 | 349.04 | 209K | 0.0000% | ||
| 8/20/25 | Buy | Director | 952 | 349.06 | 332K | 0.0000% | ||
| 8/20/25 | Buy | Director | 800 | 349.03 | 279K | 0.0000% | ||
| 8/11/25 | Sell | Executive/Senior Manager | 28,710 | 295.00 | 8.47M | 0.0008% | ||
| 8/7/25 | Sell | Chief Technology Officer | 13,950 | 316.48 | 4.41M | 0.0004% | ||
| 8/7/25 | Sell | Chief Technology Officer | 74 | 316.75 | 23.44K | 0.0000% | ||
| 11/4/21 | Sell | Chief Executive Officer | 6,500 | 719.98 | 4.68M | 0.0004% | ||
| 8/11/21 | Buy | Director | 38 | 638.50 | 24.26K | 0.0000% | ||
| 8/11/21 | Buy | Director | 25 | 638.50 | 15.96K | 0.0000% | ||
| 8/11/21 | Buy | Director | 42 | 638.50 | 26.82K | 0.0000% | ||
| 8/11/21 | Buy | Director | 50 | 638.50 | 31.92K | 0.0000% | ||
| 8/11/21 | Buy | Director | 45 | 638.50 | 28.73K | 0.0000% | ||
| 8/10/21 | Sell | Director | 158 | 636.10 | 101K | 0.0000% | ||
| 8/9/21 | Buy | Director | 500 | 639.96 | 320K | 0.0000% | ||
- Stock Market
- Stocks
- NOVO B Stock
- Company Novo Nordisk A/S
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
